Health indignity: A Carmichael hospital denied a trans man his hysterectomy. Now he’s suing.

Dignity Health moves patient’s surgery to another hospital over Catholic directives

newsreview.com

Dave Kempa

Two days before Evan Minton’s scheduled hysterectomy last September at Dignity Health Mercy San Juan Medical Center, a nurse called to discuss pre- and post-operation care. Toward the end of the call, Minton had a request.

“‘I just want to let you know that I’m transgender and my pronouns mean a great deal to me,'” he recalled saying.

According to Minton, the nurse was affirming. He hung up with a positive feeling. But the next day his doctor called with bad news. The hospital had canceled the procedure. He was terrified that the cancellation would add months or years to his physical transition.

Now, seven months later, the 35-year-old is teaming up with the American Civil Liberties Union to sue Dignity Health for denying care to a transgender patient. . . [Full text]

 

Woman Who Identifies as Man Sues Catholic Hospital for Disallowing Uterus Removal at Facility

Christian News

Heather Clark

SAN FRANCISCO, Calif. — A California woman who identifies as a man has filed a lawsuit against a Catholic hospital and its parent company for prohibiting her surgeon from performing a sex change-related hysterectomy at the facility because of the organization’s religious convictions.

The 35-year-old woman, who goes by the name Evan Minton, had been scheduled to undergo a complete hysterectomy at Mercy San Juan Medical Center in Carmichael last August. She believed the procedure was necessary to comport with her preferred identity.

However, the day before her appointment, after she noted to a nurse that she identifies as “transgender,” the surgery was canceled.

“In general, it is our practice not to provide sterilization services at Dignity Health’s Catholic facilities,” said spokeswoman Melissa Jue in a statement at the time. . . [Full text]

If sex reassignment surgery is the answer, what is the question?

BioEdge

Michael Cook*

Sex reassignment surgery requires the intervention of doctors. But what kind of treatment is it? Is it a therapy for a disease which should be offered only after psychiatric authorization? Or is it a biomedical enhancement which anyone can freely choose?

The answer to this theoretical question has practical consequences. If it is a therapy, then transgenderism is a disease. If it is an enhancement, then it hardly deserves to be funded by the government.

In a very interesting article in the Journal of Medicine and Philosophy, Tomislav Bracanović, of the University of Zagreb, in Croatia, analyses the competing conceptions. . . [Full text]

 

Doctors told not to call pregnant women “mothers”

Bioedge

Xavier Symons

British doctors have been told not to call pregnant women ‘mothers’ in a British Medical Association (BMA) document that has been slammed by conservative commentators.

In a booklet entitled A Guide To Effective Communication: Inclusive Language In The Workplace, doctors are instructed to use “inclusive language” that demonstrates “a commitment to equality and inclusion”. This includes revising conventional language used during pregnancy:

“Gender inequality is reflected in traditional ideas about the roles of women and men…We can include intersex men and transmen who may get pregnant by saying ‘pregnant people’ instead of ‘expectant mothers’.”

In an introduction to the guide on the BMA’s website, senior executive Dr Anthea Mowat wrote: ‘I would encourage you all to read and share this guide, and think about how you can apply it in your day-to-day work. This is a time where we need to come together to support and protect our colleagues and our patients.’

Conservative MP Philip Davies described the guidance as ‘completely ridiculous’: “If you can’t call a pregnant woman an expectant mother, then what is the world coming to?'”

Women’s rights campaigner Laura Perrins was equally critical of the document:

‘As every doctor knows only females can have children. To say otherwise is offensive and dangerous. This will offend women up and down the country, and is an example of the majority of women being insulted for a tiny minority of people.’

The BMA controversy comes just weeks after British media outlets reported the ‘first male pregnancy’, involving a transgender who halted her gender transition to being a male so that she could have a child.


Doctors told not to call pregnant women "mothers"This article is published by Xavier Symons and BioEdge under a Creative Commons licence. You may republish it or translate it free of charge with attribution for non-commercial purposes following these guidelines. If you teach at a university we ask that your department make a donation to BioEdge. Commercial media must contact BioEdge for permission and fees.

 

What you need to know and do about the new HHS transgender mandate

CMDA – The Point

Jonathon Imbody

What do healthcare professionals and health institutions need to know about and how can they defend themselves from the Obama administration’s newly enacted transgender mandate?

What happened when?
The transgender mandate, promulgated by the U.S. Department of Health and Human Services (HHS) under the assumed authority of the Affordable Care Act (Obamacare), went into effect July 18, 2016. A new website explains what the mandate requires, why it violates the law and what conscientious objectors can do to protect their rights.

Whom does the rule target?
HHS recently mandated that healthcare professionals must perform gender transition procedures on any child referred by a mental health professional, even if the physician believes the treatment or hormone therapy could harm the child.

Healthcare professionals who follow the Hippocratic Oath to act in the best interest of their patient instead of this new mandate can face severe consequences, including losing their jobs. The transgender mandate also requires virtually all private insurance companies and many employers to cover gender transition procedures or face stiff penalties and legal action. . . [Full text]